This trial is evaluating whether Vibrator will improve 3 primary outcomes in patients with Pelvic Floor Disorders. Measurement will happen over the course of baseline, post intervention at 3 months.
This trial requires 100 total participants across 2 different treatment groups
This trial involves 2 different treatments. Vibrator is the primary treatment being studied. Participants will all receive the same treatment. There is no placebo group. The treatments being tested are not being studied for commercial purposes.
Almost half of rectocele patients present with a concurrent urge sensation. An operation is often performed for rectocele. The findings in this study have led to the conclusion that it is possible to objectively diagnose rectocele using magnetic resonance imaging. Patients undergoing SUI surgery had higher rectocele severity scores and subjective scores for urinary symptoms. However, no correlation was detectable between rectocele scores and objective bladder capacity. A statistically significant decline was only detected in rectocele scores and maximal bladder capacity at 1 year. Therefore, no objective evidence can be drawn to the conclusion that rectocele can be treated.
around 25 million Americans are affected by pelvic floor disorders each year. These disorders occur most frequently in middle-aged Americans. Nearly 75% of all women and girls report that a gynecologist or OB/GYN is where they get the treatment they need for pelvic floor disorders.
Women and pelvic floor surgeons have a unique knowledge base regarding pelvic floor disorders. For some patients with pelvic floor disorders, conservative treatment can relieve symptoms while avoiding unnecessary surgery for others. The patient's physical presentation, medical history, and history of pelvic floor dysfunction should be used in the design of treatment algorithms.
The presence of fecal incontinence or constipation is more than four times more likely than the absence of these symptoms to be accompanied with other pelvic floor disorders or stress urinary incontinence. Patients with constipation should not be ignored. In patients with urinary symptoms, a complete history and physical examination should be performed before a diagnosis of stress urinary incontinence is made, even in patients without other pelvic floor symptoms.
Patients with pelvic floor disorders need to be informed of the importance of pelvic floor education in order to decrease the occurrence of pelvic organ prolapse.
Pelvic floor disorders are defined as disorders of pelvic floor muscles and connective tissues. The most common pelvic floor disorders include stress urinary incontinence and fecal incontinence. They are associated with aging, pregnancy, menopause, and chronic disease. However, the most accurate diagnosis of pelvic floor disorders should be made by the pelvic floor disorders specialist. The management of pelvic floor syndromes include pelvic floor physical therapy, lifestyle modification, drug intervention, and surgery. The surgical management of stress urinary incontinence consists of transvaginal adjustable implant or suburethral mesh repair of the urinary sphincter muscles.
Vibrator use appears to improve patients' compliance with their recommended pelvic floor muscle exercises, with consequent improvement of urinary symptoms. However, one recent study showed that use of vibrator does not seem to improve patients' compliance with pelvic floor muscle exercises and patients' pain perception. Further research is needed to compare use of vibrator with different techniques (involvulus) with other pelvic floor exercises.
Women tend to develop PFDs as they get older, but it is unknown what is the average age people get PFDs. As the prevalence of PFDs continue to increase, it is important to understand the onset, natural course and treatment for this disorder. Also, the development of new treatments should be encouraged.
More than 85% of women had a primary cause of pelvic floor dysfunction which included aging, pregnancy, and childbirth history, whereas 3.5% had a secondary cause.
Vibrators have side effects which include burning, irritation, redness of the vagina, and vaginal tearing. These side effects are caused by rubbing against vaginal walls. Vibrators should be used by [women under the age of 25] in order to [avoid irritation of vaginal walls] and [increase the enjoyment of vibrators]. However, some [women of reproductive age] [might] use vibrators as well. Thus, it is a matter of [women's choice] about whether they [will] use vibrators, which can [increase vaginal lubrication] and make [them] feel more comfortable [during intercourse].
Vibrator is an attractive adjunct therapy and seems to be well received by the majority of women undergoing pelvic floor disorder. The advantages are minimal pain, minimal side effects and ease of use.
The first vibrator clinical trial was undertaken by H.L. in 1987. A number of other clinical trials regarding the vibrator have been reported, some of which were published in refereed scientific journals. These trials represent the preliminary results of the use of the vibrator in various situations in relation to women's health. The first published article on the use of the vibrator for women experiencing pelvic pain or discomfort was reported in 2003. Results from a recent paper from both these studies, however, are still highly controversial.